RU92016457A -
ANTICOAGULATING PREPARATION
- Google Patents
ANTICOAGULATING PREPARATION
Info
Publication number
RU92016457A
RU92016457ARU92016457/14ARU92016457ARU92016457ARU 92016457 ARU92016457 ARU 92016457ARU 92016457/14 ARU92016457/14 ARU 92016457/14ARU 92016457 ARU92016457 ARU 92016457ARU 92016457 ARU92016457 ARU 92016457A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ново Нордиск А/СfiledCriticalНово Нордиск А/С
Publication of RU92016457ApublicationCriticalpatent/RU92016457A/en
201000007368coagulation protein diseaseDiseases0.000claims1
229920000669heparinPolymers0.000claims1
239000003112inhibitorSubstances0.000claims1
230000002401inhibitory effectEffects0.000claims1
230000037361pathwayEffects0.000claims1
230000002265preventionEffects0.000claims1
Claims (1)
Антикоагулирующий препарат предназначен для профилактики или лечения нарушений свертывания крови или рака, при этом ингибитор внешнего пути (EPI) применяют вместе с гепарином или другим мукополисахаридом. Использование антикоагулирующего препарата повышает коагулирующую активность, а также увеличивает период полураспада инъектированного EPI в плазме.The anticoagulant drug is intended for the prevention or treatment of coagulation disorders or cancer, while the external pathway inhibitor (EPI) is used together with heparin or another mucopolysaccharide. The use of an anticoagulant drug increases coagulating activity and also increases the half-life of the injected EPI in plasma.
Protective device against damage to the health of the blood, in particular thromboses, embolisms, vascular spasms, hemorrhages, hemopathies and the presence of abnormal elements in the blood.